BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 22920838)

  • 1. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
    Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
    Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
    Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
    Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation.
    Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C; Tian X; Wang J
    J Cell Biochem; 2018 Feb; 119(2):1879-1888. PubMed ID: 28815768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2/M cell cycle arrest.
    Chen W; Yan Y; Song C; Ding Y; Du T
    Biochem J; 2017 Dec; 474(24):4207-4218. PubMed ID: 29150436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
    Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
    Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
    Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
    Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.
    Barakat M; Hussein AM; Salama MF; Awadalla A; Barakat N; Serria M; El-Shafey M; El-Sherbiny M; El Adl MA
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
    Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
    Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Original article anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury.
    Liu H; McTaggart SJ; Johnson DW; Gobe GC
    Cytotherapy; 2012 Feb; 14(2):162-72. PubMed ID: 21954833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats.
    Zhang G; Zou X; Miao S; Chen J; Du T; Zhong L; Ju G; Liu G; Zhu Y
    PLoS One; 2014; 9(3):e92129. PubMed ID: 24637475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury.
    Tsuda H; Yamahara K; Otani K; Okumi M; Yazawa K; Kaimori JY; Taguchi A; Kangawa K; Ikeda T; Takahara S; Isaka Y
    Cell Transplant; 2014; 23(7):889-99. PubMed ID: 23562186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of anti-fibrotic factors ameliorates anti-fibrotic properties of Wharton's jelly derived mesenchymal stem cells under oxidative damage.
    Nimsanor N; Phetfong J; Kitiyanant N; Kamprom W; Supokawej A
    Biosci Trends; 2019 Nov; 13(5):411-422. PubMed ID: 31656260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo.
    Hu S; Li J; Xu X; Liu A; He H; Xu J; Chen Q; Liu S; Liu L; Qiu H; Yang Y
    Stem Cell Res Ther; 2016 Apr; 7(1):66. PubMed ID: 27129877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells from foreign body granulation tissue accelerate recovery from acute kidney injury.
    Patel J; Pancholi N; Gudehithlu KP; Sethupathi P; Hart PD; Dunea G; Arruda JA; Singh AK
    Nephrol Dial Transplant; 2012 May; 27(5):1780-6. PubMed ID: 22036939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction.
    Ju GQ; Cheng J; Zhong L; Wu S; Zou XY; Zhang GY; Gu D; Miao S; Zhu YJ; Sun J; Du T
    PLoS One; 2015; 10(3):e0121534. PubMed ID: 25793303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
    Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.